Novartis Investigative Site

Savannah, Georgia 31419

0 studies enrolling now · 14 studies all time

What they study most

Asthma, Atherosclerosis, Breast Cancer, Breast Neoplasms, Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease (COPD) With Cachexia, Leukaemia, Lymphocytic, Chronic, Moderate to Severe Allergic Asthma, Neoplasms, Breast, Psoriasis, Purpura, Thrombocytopaenic, Idiopathic, Relapsing Multiple Sclerosis

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod — Completed
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis — Completed
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• Study of Secukinumab With 2 mL Pre-filled Syringes — Completed
• EXTEND (Eltrombopag Extended Dosing Study) — Completed
• BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia — Completed
• A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. — Completed
• Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma — Completed
• Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma — Completed